The appeal was allowed, and the writ petition in the High Court was dismissed. The court directed the government to dispose of review applications promptly, ensuring fair hearings for manufacturers. The manufacturers' undertakings during the interim period were deemed to continue, and the court underscored the necessity of balancing procedural fairness with public interest in the price fixation of essential commodities like drugs.